Gyre Therapeutics (GYRE) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.92% |
| Dec 31, 2025 | -21.20% |
| Sep 30, 2025 | 10.14% |
| Jun 30, 2025 | -13.54% |
| Mar 31, 2025 | -44.56% |
| Dec 31, 2024 | -31.26% |
| Sep 30, 2024 | -28.52% |
| Jun 30, 2024 | -1.48% |
| Mar 31, 2024 | -19.08% |
| Dec 31, 2023 | -22.40% |
| Sep 30, 2023 | -42.82% |
| Jun 30, 2023 | -24.35% |
| Mar 31, 2023 | -36.91% |
| Dec 31, 2022 | -7.73% |
| Sep 30, 2022 | 16.05% |
| Jun 30, 2022 | 18.41% |
| Mar 31, 2022 | 19.09% |
| Dec 31, 2021 | 34.00% |
| Sep 30, 2021 | 44.73% |
| Jun 30, 2021 | 45.39% |
| Mar 31, 2021 | 39.06% |
| Dec 31, 2020 | 22.99% |
| Sep 30, 2020 | 1.53% |
| Jun 30, 2020 | 91.43% |
| Mar 31, 2020 | 102.45% |
| Dec 31, 2019 | 118.48% |
| Sep 30, 2019 | 88.17% |
| Jun 30, 2019 | -16.76% |
| Mar 31, 2019 | -11.09% |
| Dec 31, 2018 | 111.28% |
| Sep 30, 2018 | -10.23% |
| Jun 30, 2018 | -5.90% |
| Mar 31, 2018 | 12.62% |
| Dec 31, 2017 | 61.73% |
| Sep 30, 2017 | -32.48% |
| Jun 30, 2017 | -14.68% |
| Mar 31, 2017 | -30.35% |
| Dec 31, 2016 | -37.46% |
| Sep 30, 2016 | -41.02% |
| Jun 30, 2016 | -41.69% |
| Mar 31, 2016 | -31.74% |
| Dec 31, 2015 | -29.40% |
| Sep 30, 2015 | -34.10% |
| Jun 30, 2015 | -59.87% |